Celgene will buy drug developer Receptos for $7.32 billion
Cancer drug maker Celgene said it will buy Receptos for $7.32 billion in cash, gaining a drug Receptos is studying as a treatment for multiple sclerosis and ulcerative colitis.
Jul 14, 2015
0
10